Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Operative management of Crohn disease of the small bowel, colon, and rectum

Phillip R Fleshner, MD, FACS
Section Editor
Martin Weiser, MD
Deputy Editor
Wenliang Chen, MD, PhD


Crohn disease is a chronic, unremitting, incurable inflammatory disorder that can affect any segment of the gastrointestinal tract as well as extraintestinal sites [1]. The mainstay of the treatment for Crohn disease is medical. However, one in two patients with Crohn disease can expect to have at least one surgical procedure due to complications or refractory symptoms.

Surgical and endoscopic management of Crohn disease of the small bowel, colon, and rectum is discussed in this topic. The clinical manifestations and diagnosis of Crohn disease, medical therapy for patients with Crohn disease, and extraintestinal manifestations of Crohn disease are discussed elsewhere. (See "Clinical manifestations, diagnosis and prognosis of Crohn disease in adults" and "Overview of the medical management of mild to moderate Crohn disease in adults" and "Overview of the medical management of severe or refractory Crohn disease in adults" and "Perianal complications of Crohn disease".)


Operative management is indicated in patients with Crohn disease of the small bowel, colon or rectum for [1,2]:

Bowel perforation (see "Overview of gastrointestinal tract perforation", section on 'Inflammatory bowel disease')

Intra-abdominal, retroperitoneal, or abdominal wall abscess refractory to nonoperative management (see "Overview of the medical management of severe or refractory Crohn disease in adults", section on 'Abscesses')

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Oct 2017. | This topic last updated: Nov 17, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Strong S, Steele SR, Boutrous M, et al. Clinical Practice Guideline for the Surgical Management of Crohn's Disease. Dis Colon Rectum 2015; 58:1021.
  2. Jones DW, Finlayson SR. Trends in surgery for Crohn's disease in the era of infliximab. Ann Surg 2010; 252:307.
  3. Werbin N, Haddad R, Greenberg R, et al. Free perforation in Crohn's disease. Isr Med Assoc J 2003; 5:175.
  4. Fleshman JW. Pyogenic complications of Crohn's disease, evaluation, and management. J Gastrointest Surg 2008; 12:2160.
  5. Cellini C, Safar B, Fleshman J. Surgical management of pyogenic complications of Crohn's disease. Inflamm Bowel Dis 2010; 16:512.
  6. Neufeld D, Keidar A, Gutman M, Zissin R. Abdominal wall abscesses in patients with Crohn's disease: clinical outcome. J Gastrointest Surg 2006; 10:445.
  7. Xie Y, Zhu W, Li N, Li J. The outcome of initial percutaneous drainage versus surgical drainage for intra-abdominal abscesses in Crohn's disease. Int J Colorectal Dis 2012; 27:199.
  8. Poritz LS, Koltun WA. Percutaneous drainage and ileocolectomy for spontaneous intraabdominal abscess in Crohn's disease. J Gastrointest Surg 2007; 11:204.
  9. Tzivanakis A, Singh JC, Guy RJ, et al. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery. Dis Colon Rectum 2012; 55:558.
  10. Lau C, Dubinsky M, Melmed G, et al. The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. Ann Surg 2015; 261:487.
  11. Li G, Ren J, Wang G, et al. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn's disease. Eur J Clin Nutr 2014; 68:441.
  12. Kotze PG, Coy CS. The impact of preoperative anti-TNF in surgical and infectious complications of abdominal procedures for Crohn's disease: controversy still persists. Am J Gastroenterol 2014; 109:139.
  13. Subramanian V, Pollok RC, Kang JY, Kumar D. Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators. Br J Surg 2006; 93:793.
  14. Colombel JF, Loftus EV Jr, Tremaine WJ, et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99:878.
  15. Marchal L, D'Haens G, Van Assche G, et al. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 2004; 19:749.
  16. Gaertner WB, Decanini A, Mellgren A, et al. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Dis Colon Rectum 2007; 50:1754.
  17. Nasir BS, Dozois EJ, Cima RR, et al. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease. J Gastrointest Surg 2010; 14:1859.
  18. Myrelid P, Marti-Gallostra M, Ashraf S, et al. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy. Br J Surg 2014; 101:539.
  19. Ahmed Ali U, Martin ST, Rao AD, Kiran RP. Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease. Dis Colon Rectum 2014; 57:663.
  20. Papaconstantinou I, Zeglinas C, Gazouli M, et al. The impact of peri-operative anti-TNF treatment on anastomosis-related complications in Crohn's disease patients. A critical review. J Gastrointest Surg 2014; 18:1216.
  21. White EC, Melmed GY, Vasiliauskas E, et al. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease? Dis Colon Rectum 2012; 55:563.
  22. Pozza A, Scarpa M, Lacognata C, et al. Magnetic resonance enterography for Crohn's disease: what the surgeon can take home. J Gastrointest Surg 2011; 15:1689.
  23. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 2009; 193:113.
  24. Malgras B, Soyer P, Boudiaf M, et al. Accuracy of imaging for predicting operative approach in Crohn's disease. Br J Surg 2012; 99:1011.
  25. Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology 2009; 251:751.
  26. Qiu Y, Mao R, Chen BL, et al. Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease. Aliment Pharmacol Ther 2014; 40:134.
  27. Schapira M, Henrion J, Ravoet C, et al. Thromboembolism in inflammatory bowel disease. Acta Gastroenterol Belg 1999; 62:182.
  28. Irving PM, Pasi KJ, Rampton DS. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 2005; 3:617.
  29. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:381S.
  30. Nguyen GC, Bernstein CN, Bitton A, et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology 2014; 146:835.
  31. Laine L, Hanauer SB. Considerations in the management of steroid-dependent Crohn's disease. Gastroenterology 2003; 125:906.
  32. Delaney CP, Kiran RP, Senagore AJ, et al. Quality of life improves within 30 days of surgery for Crohn's disease. J Am Coll Surg 2003; 196:714.
  33. Fazio VW, Marchetti F, Church M, et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial. Ann Surg 1996; 224:563.
  34. Hotokezaka M, Jimi SI, Hidaka H, et al. Role of intraoperative enteroscopy for surgical decision making with Crohn's disease. Surg Endosc 2007; 21:1238.
  35. Michelassi F. Crohn's recurrence after intestinal resection and anastomosis. Dig Dis Sci 2014; 59:1352.
  36. Simillis C, Purkayastha S, Yamamoto T, et al. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease. Dis Colon Rectum 2007; 50:1674.
  37. Kono T, Ashida T, Ebisawa Y, et al. A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn's disease. Dis Colon Rectum 2011; 54:586.
  38. Huang R, Valerian BT, Lee EC. Laparoscopic approach in patients with recurrent Crohn's disease. Am Surg 2012; 78:595.
  39. Hasegawa H, Watanabe M, Nishibori H, et al. Laparoscopic surgery for recurrent Crohn's disease. Br J Surg 2003; 90:970.
  40. Tan JJ, Tjandra JJ. Laparoscopic surgery for Crohn's disease: a meta-analysis. Dis Colon Rectum 2007; 50:576.
  41. Lee Y, Fleming FJ, Deeb AP, et al. A laparoscopic approach reduces short-term complications and length of stay following ileocolic resection in Crohn's disease: an analysis of outcomes from the NSQIP database. Colorectal Dis 2012; 14:572.
  42. Chaudhary B, Glancy D, Dixon AR. Laparoscopic surgery for recurrent ileocolic Crohn's disease is as safe and effective as primary resection. Colorectal Dis 2011; 13:1413.
  43. Aytac E, Stocchi L, Remzi FH, Kiran RP. Is laparoscopic surgery for recurrent Crohn's disease beneficial in patients with previous primary resection through midline laparotomy? A case-matched study. Surg Endosc 2012; 26:3552.
  44. Bergamaschi R, Pessaux P, Arnaud JP. Comparison of conventional and laparoscopic ileocolic resection for Crohn's disease. Dis Colon Rectum 2003; 46:1129.
  45. Young-Fadok TM, HallLong K, McConnell EJ, et al. Advantages of laparoscopic resection for ileocolic Crohn's disease. Improved outcomes and reduced costs. Surg Endosc 2001; 15:450.
  46. Patel SV, Patel SV, Ramagopalan SV, Ott MC. Laparoscopic surgery for Crohn's disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery. BMC Surg 2013; 13:14.
  47. Malireddy K, Larson DW, Sandborn WJ, et al. Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease. Arch Surg 2010; 145:42.
  48. Lowney JK, Dietz DW, Birnbaum EH, et al. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn's disease compared with conventional surgery? A long-term, follow-up study. Dis Colon Rectum 2006; 49:58.
  49. Morimoto K, Watanabe K, Noguchi A, et al. Clinical impact of ultrathin colonoscopy for Crohn's disease patients with strictures. J Gastroenterol Hepatol 2015; 30 Suppl 1:66.
  50. Tekkis PP, Purkayastha S, Lanitis S, et al. A comparison of segmental vs subtotal/total colectomy for colonic Crohn's disease: a meta-analysis. Colorectal Dis 2006; 8:82.
  51. Lewis JD, Schoenfeld P, Lichtenstein GR. An evidence-based approach to studies of the natural history of gastrointestinal diseases: recurrence of symptomatic Crohn's disease after surgery. Clin Gastroenterol Hepatol 2003; 1:229.
  52. Bernell O, Lapidus A, Hellers G. Recurrence after colectomy in Crohn's colitis. Dis Colon Rectum 2001; 44:647.
  53. Yamamoto T, Watanabe T. Surgery for luminal Crohn's disease. World J Gastroenterol 2014; 20:78.
  54. Cirincione E, Gorfine SR, Bauer JJ. Is Hartmann's procedure safe in Crohn's disease? Report of three cases. Dis Colon Rectum 2000; 43:544.
  55. Bauer JJ, Gelernt IM, Salk BA, Kreel I. Proctectomy for inflammatory bowel disease. Am J Surg 1986; 151:157.
  56. Zeitels JR, Fiddian-Green RG, Dent TL. Intersphincteric proctectomy. Surgery 1984; 96:617.
  57. Lewis RT, Bleier JI. Surgical treatment of anorectal crohn disease. Clin Colon Rectal Surg 2013; 26:90.
  58. Fichera A, McCormack R, Rubin MA, et al. Long-term outcome of surgically treated Crohn's colitis: a prospective study. Dis Colon Rectum 2005; 48:963.
  59. Hesham W, Kann BR. Strictureplasty. Clin Colon Rectal Surg 2013; 26:80.
  60. Dietz DW, Fazio VW, Laureti S, et al. Strictureplasty in diffuse Crohn's jejunoileitis: safe and durable. Dis Colon Rectum 2002; 45:764.
  61. Bellolio F, Cohen Z, MacRae HM, et al. Strictureplasty in selected Crohn's disease patients results in acceptable long-term outcome. Dis Colon Rectum 2012; 55:864.
  62. Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis. Dis Colon Rectum 2007; 50:1968.
  63. Tonelli F, Fazi M, Di Martino C. Ileocecal strictureplasty for Crohn's disease: long-term results and comparison with ileocecal resection. World J Surg 2010; 34:2860.
  64. Dietz DW, Laureti S, Strong SA, et al. Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn's disease. J Am Coll Surg 2001; 192:330.
  65. Fearnhead NS, Chowdhury R, Box B, et al. Long-term follow-up of strictureplasty for Crohn's disease. Br J Surg 2006; 93:475.
  66. Michelassi F, Upadhyay GA. Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease. J Surg Res 2004; 117:71.
  67. Sampietro GM, Cristaldi M, Maconi G, et al. A prospective, longitudinal study of nonconventional strictureplasty in Crohn's disease. J Am Coll Surg 2004; 199:8.
  68. Tonelli F, Fedi M, Paroli GM, Fazi M. Indications and results of side-to-side isoperistaltic strictureplasty in Crohn's disease. Dis Colon Rectum 2004; 47:494.
  69. Michelassi F, Taschieri A, Tonelli F, et al. An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn's disease. Dis Colon Rectum 2007; 50:277.
  70. Ambe R, Campbell L, Cagir B. A comprehensive review of strictureplasty techniques in Crohn's disease: types, indications, comparisons, and safety. J Gastrointest Surg 2012; 16:209.
  71. Fazi M, Giudici F, Luceri C, et al. Long-term Results and Recurrence-Related Risk Factors for Crohn Disease in Patients Undergoing Side-to-Side Isoperistaltic Strictureplasty. JAMA Surg 2016; 151:452.
  72. Campbell L, Ambe R, Weaver J, et al. Comparison of conventional and nonconventional strictureplasties in Crohn's disease: a systematic review and meta-analysis. Dis Colon Rectum 2012; 55:714.
  73. Bhalme M, Sarkar S, Lal S, et al. Endoscopic balloon dilatation of Crohn's disease strictures: results from a large United kingdom series. Inflamm Bowel Dis 2014; 20:265.
  74. Ono Y, Hirai F, Matsui T, et al. Value of concomitant endoscopic balloon dilation for intestinal stricture during long-term infliximab therapy in patients with Crohn's disease. Dig Endosc 2012; 24:432.
  75. Hassan C, Zullo A, De Francesco V, et al. Systematic review: Endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007; 26:1457.
  76. Thienpont C, D'Hoore A, Vermeire S, et al. Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy. Gut 2010; 59:320.
  77. Morar PS, Faiz O, Warusavitarne J, et al. Systematic review with meta-analysis: endoscopic balloon dilatation for Crohn's disease strictures. Aliment Pharmacol Ther 2015; 42:1137.
  78. Li Y, Stocchi L, Shen B, et al. Salvage surgery after failure of endoscopic balloon dilatation versus surgery first for ileocolonic anastomotic stricture due to recurrent Crohn's disease. Br J Surg 2015; 102:1418.
  79. Di Nardo G, Oliva S, Passariello M, et al. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointest Endosc 2010; 72:1201.
  80. East JE, Brooker JC, Rutter MD, Saunders BP. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures. Clin Gastroenterol Hepatol 2007; 5:1065.
  81. De Cruz P, Kamm MA, Prideaux L, et al. Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm Bowel Dis 2012; 18:758.
  82. Avidan B, Sakhnini E, Lahat A, et al. Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion 2005; 72:248.
  83. Leal-Valdivieso C, Marín I, Mañosa M, et al. Should we monitor Crohn's disease patients for postoperative recurrence after permanent ileostomy? Inflamm Bowel Dis 2012; 18:E196.
  84. Maykel JA, Hagerman G, Mellgren AF, et al. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum 2006; 49:950.